Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azacitidine-CHOP in nodal T-cell lymphoma with T-follicular helper phenotype
KCT0006961Phase 2Not yet recruiting
- Sponsor
- Boryung
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in peripheral T-cell lymphoma (PTCL), sponsored by Boryung. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
azacitidine
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on KCT0006961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006961.